In addition to this primary outcome, some secondary outcomes will be measured: miscarriage, gestational diabetes mellitus, premature rupture of membranes, placental abruption, intrahepatic cholestasis of pregnancy, fetal distress, macrosomia, and neonates admitted Use is considered acceptable AU TGA pregnancy category: A US FDA pregnancy category: Not Assigned Risk Summary: No increased rates of major birth defects or miscarriages have been reported with use during pregnancy; untreated hypothyroidism during pregnancy is associated with risks to the
Levothyroxine replacement therapy may decrease the risk of adverse pregnancy outcomes among women with subclinical hypothyroidism (SCH)
Levothyroxine: little to no effect on hypertensive disorders and abruption; reduces miscarriage and preterm birth, and improves fetal intellectual development
In this study, we found that L-T4 treatment of hypothyroxinemia in early pregnancy can reduce the occurrence of miscarriage
Untreated hypothyroidism can be harmful to you and your baby
Researchers from the University of Chicago have showed, for the first time, that an excess of thyroid hormone during pregnancy has a direct toxic effect on the